PharmTech News

Feliza Mirasol is the science editor for 

Articles

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's  IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.

Ascend Advanced Therapies Expands US Footprint in New Partnership

The companies will work to create climate-friendly pMDIs using Orbia’s low global warming potential propellant.

Bespak and Orbia Fluor & Energy Materials Collaborate on Climate-Friendly Inhalers

A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product.

Aptamer Extends Agreement for Drug Delivery Vehicles

The merger agreement is valued at approximately $1.1 billion.

Avid Bioservices Acquired by GHO Capital Partners and Ampersand Capital Partners

Synaffix, a Lonza company, has licensed its ADC technology to BigHat Biosciences to be combined with the latter's ML design platform to develop new ADCs

Synaffix, a Lonza Company, Collaborates with BigHat Biosciences on ADCs Designed Using Machine Learning

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.

Abzena Expands Microbiology Laboratory Space

Evonik won the CPHI Excellence in Pharma Award in the “Sustainability” category in recognition of its plant-based squalene, PhytoSquene, used in parenteral drug delivery applications.

Evonik Wins Award at CPHI Milan for Plant-based Parenteral Drug Delivery Adjuvant

Through the global partnership, Colorcon will exclusively represent LOTTE’s AnyCoat Hypromellose products.

Colorcon and LOTTE Fine Chemical Announce Partnership

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

Supplier News